Product Information

METFORMIN HCL 850 MG TABLET is a generic product labeled by Laurus Labs Limited, priced at $0.0239 per EA under NDC 42385094811. Its NADAC has been published 182 times since Mar 1, 2023.

FDA first approved this application on Aug 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN HCL 850 MG TABLET

Metformin Hydrochloride
$0.0239per EA

Strength

850 mg/1

NDC

42385094811

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209882

FDA Approved

8/27/2018

TE Code

AB

On Market Since

5/17/2021

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL 850 MG TABLET has been published 182 times since Mar 1, 2023, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0239 per EA
All-time high$0.0297 (Mar 15, 2023)
All-time low$0.0196 (May 22, 2024)
52-week high$0.0248
52-week low$0.0224
Median price$0.0244
Average price$0.0245
Largest weekly change+26.0% (Jun 19, 2024)
Weeks tracked182
Tracking sinceMar 1, 2023

Price History

1W

-2.7%

1M

-3.2%

3M

-3.8%

6M

-1.9%

1Y

+4.7%

3Y

-15.8%

5Y

N/A

All

-19.5%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METFORMIN HCL 850 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Laurus Labs Limited, is $0.0239 per EA (NDC 42385094811), effective Aug 19, 2026.

How has the price of METFORMIN HCL 850 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 19.5%. It has been tracked across 182 weekly CMS publications since Mar 1, 2023.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?

Since Mar 1, 2023, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0297 (Mar 15, 2023), with a median of $0.0244 per EA.

Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?

13 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 850 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METFORMIN HCL 850 MG TABLET?

METFORMIN HCL 850 MG TABLET (NDC 42385094811) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.